Taiwan · Delayed Price · Currency is TWD ICARES Medicus Statistics
Total Valuation
ICARES Medicus has a market cap or net worth of TWD 3.44 billion. The enterprise value is 3.68 billion.
| Market Cap | 3.44B |
| Enterprise Value | 3.68B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Aug 22, 2025 |
Share Statistics
ICARES Medicus has 47.52 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Current Share Class | 47.52M |
| Shares Outstanding | 47.52M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | 21.58% |
| Owned by Institutions (%) | 0.26% |
| Float | 23.12M |
Valuation Ratios
The trailing PE ratio is 81.61.
| PE Ratio | 81.61 |
| Forward PE | n/a |
| PS Ratio | 3.04 |
| PB Ratio | 1.72 |
| P/TBV Ratio | 3.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 206.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.93, with an EV/FCF ratio of -36.70.
| EV / Earnings | 87.17 |
| EV / Sales | 3.25 |
| EV / EBITDA | 13.93 |
| EV / EBIT | 32.57 |
| EV / FCF | -36.70 |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.07 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 3.16 |
| Debt / FCF | -8.38 |
| Interest Coverage | 4.83 |
Financial Efficiency
Return on equity (ROE) is -0.53% and return on invested capital (ROIC) is -1.05%.
| Return on Equity (ROE) | -0.53% |
| Return on Assets (ROA) | 2.28% |
| Return on Invested Capital (ROIC) | -1.05% |
| Return on Capital Employed (ROCE) | 4.85% |
| Weighted Average Cost of Capital (WACC) | 4.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.13 |
Taxes
In the past 12 months, ICARES Medicus has paid 62.02 million in taxes.
| Income Tax | 62.02M |
| Effective Tax Rate | 119.25% |
Stock Price Statistics
The stock price has decreased by -34.99% in the last 52 weeks. The beta is 0.25, so ICARES Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -34.99% |
| 50-Day Moving Average | 69.55 |
| 200-Day Moving Average | 82.06 |
| Relative Strength Index (RSI) | 55.90 |
| Average Volume (20 Days) | 61,033 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ICARES Medicus had revenue of TWD 1.13 billion and earned 42.22 million in profits. Earnings per share was 0.89.
| Revenue | 1.13B |
| Gross Profit | 662.51M |
| Operating Income | 115.01M |
| Pretax Income | 52.01M |
| Net Income | 42.22M |
| EBITDA | 228.27M |
| EBIT | 115.01M |
| Earnings Per Share (EPS) | 0.89 |
Balance Sheet
The company has 720.97 million in cash and 840.26 million in debt, with a net cash position of -119.29 million or -2.51 per share.
| Cash & Cash Equivalents | 720.97M |
| Total Debt | 840.26M |
| Net Cash | -119.29M |
| Net Cash Per Share | -2.51 |
| Equity (Book Value) | 2.00B |
| Book Value Per Share | 39.71 |
| Working Capital | 887.22M |
Cash Flow
In the last 12 months, operating cash flow was 16.69 million and capital expenditures -116.96 million, giving a free cash flow of -100.27 million.
| Operating Cash Flow | 16.69M |
| Capital Expenditures | -116.96M |
| Depreciation & Amortization | 113.26M |
| Net Borrowing | -64.66M |
| Free Cash Flow | -100.27M |
| FCF Per Share | -2.11 |
Margins
Gross margin is 58.53%, with operating and profit margins of 10.16% and 3.73%.
| Gross Margin | 58.53% |
| Operating Margin | 10.16% |
| Pretax Margin | 4.59% |
| Profit Margin | 3.73% |
| EBITDA Margin | 20.17% |
| EBIT Margin | 10.16% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.41%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.41% |
| Dividend Growth (YoY) | 65.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 30.61% |
| Buyback Yield | -0.54% |
| Shareholder Yield | -0.12% |
| Earnings Yield | 1.23% |
| FCF Yield | -2.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 22, 2025. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 22, 2025 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |